BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,457,413 | -34.2% | 464,446 | -34.6% | 0.01% | -37.5% |
| Q2 2023 | $76,641,956 | +14.9% | 710,108 | +32.6% | 0.02% | +6.7% |
| Q1 2023 | $66,730,779 | -64.0% | 535,689 | -56.6% | 0.02% | -65.9% |
| Q4 2022 | $185,460,260 | +20.0% | 1,234,591 | +7.8% | 0.04% | +25.7% |
| Q3 2022 | $154,537,000 | -45.6% | 1,145,741 | -39.9% | 0.04% | -52.1% |
| Q2 2022 | $284,183,000 | -18.5% | 1,905,985 | -6.8% | 0.07% | +1.4% |
| Q1 2022 | $348,795,000 | -45.5% | 2,044,997 | -17.6% | 0.07% | -45.0% |
| Q4 2021 | $640,141,000 | -33.7% | 2,483,092 | -29.8% | 0.13% | -34.8% |
| Q3 2021 | $965,976,000 | +137.4% | 3,538,500 | +94.7% | 0.20% | +120.9% |
| Q2 2021 | $406,872,000 | +140.2% | 1,817,368 | +17.1% | 0.09% | +122.0% |
| Q1 2021 | $169,423,000 | +137.7% | 1,551,633 | +77.5% | 0.04% | +127.8% |
| Q4 2020 | $71,261,000 | +111.5% | 874,138 | +79.6% | 0.02% | +80.0% |
| Q3 2020 | $33,690,000 | +26.6% | 486,646 | +22.0% | 0.01% | +11.1% |
| Q2 2020 | $26,613,000 | – | 398,761 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 1,053,640 | $179,709,000 | 15.52% |
| Bill & Melinda Gates Foundation | 148,674 | $25,400,000 | 13.66% |
| Baader Bank Aktiengesellschaft | 224,800 | $38,342,000 | 3.07% |
| Quinn Opportunity Partners LLC | 402,239 | $68,606,000 | 2.96% |
| Pendal Group Ltd | 1,957,594 | $333,887,000 | 2.75% |
| Boston Common Asset Management, LLC | 280,181 | $47,788,000 | 2.06% |
| Tri Locum Partners LP | 30,923 | $5,274,000 | 2.06% |
| Renaissance Capital LLC | 25,267 | $4,310,000 | 1.83% |
| Robbins Farley | 13,220 | $2,255,000 | 1.70% |
| APEIRON CAPITAL Ltd | 21,300 | $3,633,000 | 1.61% |